Sanofi’s groundbreaking treatment for Pompe disease, Nexviazyme (avalglucosidase alfa), has achieved a significant milestone with the successful completion of the…
Read More
Lifelong Mental Stimulation Linked to Significant Delay in Alzheimer’s Disease Onset and Slower Cognitive Decline
Engaging in a consistent regimen of mentally stimulating activities throughout one’s life, such as reading, writing, and the acquisition of…
Read More
Lifelong Mental Stimulation Linked to Delayed Alzheimer’s Onset and Slower Cognitive Decline
A comprehensive longitudinal study published in Neurology, the medical journal of the American Academy of Neurology, suggests that maintaining a…
Read More
Lifelong Cognitive Enrichment Linked to Significant Delays in Alzheimer’s Onset and Cognitive Decline
Engaging in a consistent regimen of mentally stimulating activities throughout the course of one’s life—ranging from childhood literacy to adult…
Read More
Lifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Onset and Slower Mental Decline
A comprehensive study published in the medical journal of the American Academy of Neurology, Neurology, has revealed a profound correlation…
Read More
Washington University Researchers Develop p-tau217 Blood Test Clock Capable of Predicting Alzheimer’s Symptom Onset Years in Advance
In a significant advancement for neurodegenerative disease research, scientists at Washington University School of Medicine in St. Louis have pioneered…
Read More
Revolutionary Blood Test Model Forecasts Alzheimer’s Symptom Onset, Reshaping Early Detection and Clinical Trial Strategies
Clinical laboratories across the globe are keenly observing a pivotal shift in neurodegenerative disease diagnostics, particularly with the escalating prominence…
Read MoreYOU MAY HAVE MISSED
